TY - JOUR
T1 - World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update – I – Plan and definitions
AU - the WAO DRACMA guideline group
AU - Fiocchi, Alessandro
AU - Bognanni, Antonio
AU - Brożek, Jan
AU - Ebisawa, Motohiro
AU - Schünemann, Holger
AU - Ansotegui, Ignacio J.
AU - Arasi, Stefania
AU - Assa'ad, Amal H.
AU - Bahna, Sami L.
AU - Canani, Roberto Berni
AU - Bozzola, Martin
AU - Chu, Derek
AU - Dahdah, Lamia
AU - Dupont, Christophe
AU - Firmino, Ramon Targino
AU - Galli, Elena
AU - Kamenwa, Rose
AU - Lack, Gideon
AU - Li, Haiqi
AU - Martelli, Alberto
AU - Nowak-Węgrzyn, Anna
AU - Papadopoulos, Nikolas G.
AU - Pawankar, Ruby
AU - Said, Maria
AU - Sánchez-Borges, Mario
AU - Shamir, Raanan
AU - Spergel, Jonathan M.
AU - Szajewska, Hania
AU - Terracciano, Luigi
AU - Vandenplas, Yvan
AU - Venter, Carina
AU - Warner, Amena
AU - Waserman, Susan
AU - Wong, Gary W.K.
N1 - Funding Information:
This document was supported by the World Allergy Organization .
Publisher Copyright:
© 2021 The Author(s)
PY - 2022/1
Y1 - 2022/1
N2 - Since the World Allergy Organization (WAO) Diagnosis and Rationale against Cow's Milk Allergy (DRACMA) Guidelines were published 10 years ago, new evidence has accumulated about the diagnosis, therapy, and specific immunotherapy for cow's milk allergy (CMA). For this reason, WAO has felt the need to update the guidelines. We introduce here this update. The new DRACMA guidelines aim to comprehensively address the guidance on diagnosis and therapy of both IgE non-IgE-mediated forms of cow's milk allergy in children and adults. They will be divided into 18 chapters, each of which will be dedicated to an aspect. The focus will be on the meta-analyzes and recommendations that will be expressed for the 3 most relevant clinical aspects: (a) the diagnostic identification of the condition; (b) the choice of the replacement formula in case of CMA in infancy when the mother is not able to breastfeed, and (c) the use of specific immunotherapy for cow's milk protein allergy.
AB - Since the World Allergy Organization (WAO) Diagnosis and Rationale against Cow's Milk Allergy (DRACMA) Guidelines were published 10 years ago, new evidence has accumulated about the diagnosis, therapy, and specific immunotherapy for cow's milk allergy (CMA). For this reason, WAO has felt the need to update the guidelines. We introduce here this update. The new DRACMA guidelines aim to comprehensively address the guidance on diagnosis and therapy of both IgE non-IgE-mediated forms of cow's milk allergy in children and adults. They will be divided into 18 chapters, each of which will be dedicated to an aspect. The focus will be on the meta-analyzes and recommendations that will be expressed for the 3 most relevant clinical aspects: (a) the diagnostic identification of the condition; (b) the choice of the replacement formula in case of CMA in infancy when the mother is not able to breastfeed, and (c) the use of specific immunotherapy for cow's milk protein allergy.
KW - Cow's milk allergy
KW - Food allergy
KW - GRADE
KW - Oral immunotherapy
UR - http://www.scopus.com/inward/record.url?scp=85123803574&partnerID=8YFLogxK
U2 - 10.1016/j.waojou.2021.100609
DO - 10.1016/j.waojou.2021.100609
M3 - Article
AN - SCOPUS:85123803574
SN - 1939-4551
VL - 15
JO - World Allergy Organization Journal
JF - World Allergy Organization Journal
IS - 1
M1 - 100609
ER -